Literature DB >> 15204751

Air pollution and cardiac arrhythmias in patients with implantable cardioverter defibrillators.

Sverre Vedal1, Kira Rich, Michael Brauer, Rick White, John Petkau.   

Abstract

Epidemiological studies have demonstrated associations between short-term increases in outdoor air pollution concentrations and adverse cardiovascular effects, including cardiac mortality and hospitalizations. One possible mechanism behind this association is that air pollution exposure increases the risk of developing a cardiac arrhythmia. To investigate this hypothesis, dates of implantable cardioverter defibrillator (ICD) discharges were abstracted from patient records in patients attending the two ICD clinics in Vancouver, BC, for the years 1997-2000. Daily outdoor air pollutant concentrations and daily meteorological data from the Vancouver region were obtained for the same 4-yr period. Generalized estimating equations were used to assess the association between short-term increases in air pollutant concentrations and ICD discharges while controlling for temporal trends, meteorology, and serial correlation in the data. Air pollution concentrations in the Vancouver region were relatively low from 1997 to 2000, as expected. In the 50 patients who resided within the Vancouver region and who experienced at least 1 ICD discharge during the period of follow-up, no significant associations between increased air pollution concentrations and increased ICD discharges were present. When the patient sample was restricted to the 16 patients who had at least 6 months of follow-up and experienced a rate of at least 2 days with ICD discharges per year, there was a statistically significant association between increased sulfur dioxide (SO(2)) concentration and ICD discharge 2 days after the SO(2) increase. When stratified by season, no associations between increased air pollutant concentrations and increased risk of ICD discharge were observed in the summer, although for several pollutants, concentration increases were associated with a decrease in ICD discharges. In the winter, increased SO(2) concentrations again were seen to be associated with increased risk of ICD discharge, at both 2 and 3 days following increases in SO(2) concentrations. These findings provide no compelling evidence that short-term increases in relatively low concentrations of outdoor air pollutants have an adverse effect on individuals at risk of cardiac arrhythmias. The findings regarding SO(2) are difficult to interpret. They may be chance findings. Alternatively, given the very low concentrations of SO(2) that were present in Vancouver, SO(2) may have been serving as a surrogate measure of other environmental or meteorological factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15204751     DOI: 10.1080/08958370490439506

Source DB:  PubMed          Journal:  Inhal Toxicol        ISSN: 0895-8378            Impact factor:   2.724


  18 in total

1.  The environmental epidemiology of atrial arrhythmogenesis.

Authors:  Eric A Whitsel; Christy L Avery
Journal:  J Epidemiol Community Health       Date:  2010-05-24       Impact factor: 3.710

2.  Association of air pollution sources and aldehydes with biomarkers of blood coagulation, pulmonary inflammation, and systemic oxidative stress.

Authors:  Brent Altemose; Mark G Robson; Howard M Kipen; Pamela Ohman Strickland; Qingyu Meng; Jicheng Gong; Wei Huang; Guangfa Wang; David Q Rich; Tong Zhu; Junfeng Zhang
Journal:  J Expo Sci Environ Epidemiol       Date:  2016-07-20       Impact factor: 5.563

3.  Environmental and occupational particulate matter exposures and ectopic heart beats in welders.

Authors:  Jennifer M Cavallari; Shona C Fang; Ellen A Eisen; Murray A Mittleman; David C Christiani
Journal:  Occup Environ Med       Date:  2016-04-06       Impact factor: 4.402

4.  Association of ventricular arrhythmias detected by implantable cardioverter defibrillator and ambient air pollutants in the St Louis, Missouri metropolitan area.

Authors:  D Q Rich; M H Kim; J R Turner; M A Mittleman; J Schwartz; P J Catalano; D W Dockery
Journal:  Occup Environ Med       Date:  2006-05-12       Impact factor: 4.402

5.  Cardiorespiratory treatments as modifiers of the relationship between particulate matter and health: a case-only analysis on hospitalized patients in Italy.

Authors:  Sara Conti; Alessandra Lafranconi; Antonella Zanobetti; Carla Fornari; Fabiana Madotto; Joel Schwartz; Giancarlo Cesana
Journal:  Environ Res       Date:  2014-11-26       Impact factor: 6.498

6.  Acute effects of fine particulate air pollution on ST segment height: a longitudinal study.

Authors:  Fan He; Michele L Shaffer; Sol Rodriguez-Colon; Edward O Bixler; Alexandros N Vgontzas; Ronald W Williams; Rongling Wu; Wayne E Cascio; Duanping Liao
Journal:  Environ Health       Date:  2010-11-08       Impact factor: 5.984

Review 7.  Air pollution and the triggering of cardiac arrhythmias.

Authors:  Mark S Link; Douglas W Dockery
Journal:  Curr Opin Cardiol       Date:  2010-01       Impact factor: 2.161

8.  Ambient particulate air pollution and ectopy--the environmental epidemiology of arrhythmogenesis in Women's Health Initiative Study, 1999-2004.

Authors:  Duanping Liao; Eric A Whitsel; Yinkang Duan; Hung-Mo Lin; P Miguel Quibrera; Richard Smith; Donna J Peuquet; Ronald J Prineas; Zhu-Ming Zhang; Garnet Anderson
Journal:  J Toxicol Environ Health A       Date:  2009

9.  Acute effects of fine particulate air pollution on cardiac arrhythmia: the APACR study.

Authors:  Fan He; Michele L Shaffer; Sol Rodriguez-Colon; Jeff D Yanosky; Edward Bixler; Wayne E Cascio; Duanping Liao
Journal:  Environ Health Perspect       Date:  2011-03-11       Impact factor: 9.031

10.  Association of air pollution with increased incidence of ventricular tachyarrhythmias recorded by implanted cardioverter defibrillators.

Authors:  Douglas W Dockery; Heike Luttmann-Gibson; David Q Rich; Mark S Link; Murray A Mittleman; Diane R Gold; Petros Koutrakis; Joel D Schwartz; Richard L Verrier
Journal:  Environ Health Perspect       Date:  2005-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.